retatrutide triumph TRIUMPH-4: Beat Every Prediction (Full Data) Retatrutide Achieves Up to 30.3%

Semiglutide is associated with Ozempic, Wegovy, and Rubelsus, affecting GLP1S

If GLP-1s do what the evidence suggests they will do, this will be one of the clearest demonstrations in modern psychiatry of why we fund preclinical research and why translational pipelines matter

Learn about potential benefits, safety considerations and what the research actually says.

As the use of GLP-1 receptor agonists continues to expand for the treatment of type 2 diabetes and obesity, questions have emerged about their potential gastrointestinal side effectsparticularly gastroesophageal reflux disease (GERD)

Any PBM reforms should seek to remove distortions from the marketand, in particular, distortions created by government policies.

Beyond prescriptions, pharmacies offer valuable healthcare services and screenings like vaccines, heart health tests and more